Afficher la notice abrégée

Cannabidiol in sport : Ergogenic or else ?

dc.rights.licenseOTHen_US
dc.contributor.authorGamelin, François-Xavier
dc.contributor.authorCuvelier, Grégory
dc.contributor.authorMendes, Antoine
dc.contributor.authorAucouturier, Julien
dc.contributor.authorBerthoin, Serge
dc.contributor.authorDi Marzo, Vincenzo
dc.contributor.authorHeyman, Elsa
dc.date.accessioned2021-04-23T12:12:32Z
dc.date.available2021-04-23T12:12:32Z
dc.date.issued2020-03-20
dc.identifier.issn1043-6618en_US
dc.identifier.urihttps://luck.synhera.be/handle/123456789/906
dc.identifier.doihttps://doi.org/10.1016/j.phrs.2020.104764en_US
dc.description.abstractIn the sports domain, cannabis is prohibited by the World Anti-Doping Agency (WADA) across all sports in competition since 2004. The few studies on physical exercise and cannabis focused on the main compound i.e. Δ9-tetrahydrocannabinol. Cannabidiol (CBD) is another well-known phytocannabinoid present in dried or heated preparations of cannabis. Unlike Δ9-tetrahydrocannabinol, CBD is non-intoxicating but exhibits pharmacological properties that are interesting for medical use. The worldwide regulatory status of CBD is complex and this compound is still a controlled substance in many countries. Interestingly, however, the World Anti-Doping Agency removed CBD from the list of prohibited substances – in or out of competition - since 2018. This recent decision by the WADA leaves the door open for CBD use by athletes. In the present opinion article we wish to expose the different CBD properties discovered in preclinical studies that could be further tested in the sport domain to ascertain its utility. Preclinical studies suggest that CBD could be useful to athletes due to its antiinflammatory, analgesic, anxiolytic, neuroprotective properties and its influence on the sleep-wake cycle. Unfortunately, almost no clinical data are available on CBD in the context of exercise, which makes its use in this context still premature.en_US
dc.description.sponsorshipNoneen_US
dc.description.tableofcontents1. Introduction 2. Overview of CBD 3. Anti-inflammatory and analgesic effects 4. Anxiolytic effects 5. Neuroprotective effects 6. Sleep disturbances 7. Limits 8. Conclusionsen_US
dc.language.isoENen_US
dc.publisherElsevieren_US
dc.relation.ispartofPharmacological Researchen_US
dc.rights.urihttps://www.elsevier.com/legal/elsevier-website-terms-and-conditionsen_US
dc.subjectAnxiolyticen_US
dc.subjectCannabidiolen_US
dc.subjectCannabisen_US
dc.subjectDopingen_US
dc.subjectNeuroprotectiveen_US
dc.subjectSleep-wake cycleen_US
dc.subject.frAnxiolytiquesen_US
dc.subject.frDopageen_US
dc.subject.frPropriétés neuroprotectricesen_US
dc.subject.frCycle éveil-sommeilen_US
dc.titleCannabidiol in sport : Ergogenic or else ?en_US
dc.typeArticle scientifiqueen_US
synhera.classificationSciences de la santé humaine>>Orthopédie, rééducation & médecine sportiveen_US
synhera.institutionHE Condorceten_US
synhera.otherinstitutionInstitute of biomolecular chemistry, Pozzuolien_US
synhera.otherinstitutionUniversité d'Artois, Lilleen_US
synhera.otherinstitutionUniversité de Laval, Quebecen_US
synhera.cost.total0en_US
synhera.cost.apc0en_US
synhera.cost.comp0en_US
synhera.cost.acccomp0en_US
dc.description.versionOuien_US
dc.rights.holderElsevieren_US


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée